# Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital

> **NCT02068170** · — · COMPLETED · sponsor: **KU Leuven** · enrollment: 178 (actual)

## Conditions studied

- Delirium
- QT-prolongation

## Interventions

- **DRUG:** Haloperidol, azi/clari/erythromycin, levo/moxifloxacin, co-trimoxazole, vori/keto/flu/itraconazole, methadone, tacrolimus, sunitinib

## Key facts

- **NCT ID:** NCT02068170
- **Lead sponsor:** KU Leuven
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-03
- **Final completion:** 2015-06
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068170, "Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02068170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*